semaglutide increases risk of what The Therapeutic Goods Administration has issued an urgent safety warning over the suicidal thoughts linked to popular drugs used to treat type 2 diabetes and obesity. The affected drugs include WEIGHT LOSS OUTCOMES WITH SEMAGLUTIDE

Patients with: Personal or family history of Medullary thyroid cancer MEN2 syndrome Severe gastroparesis Pregnancy/ breastfeeding Pancreatitis or breastfeeding Severe depression Eating disorders Liver or kidney disease (caution advised) Why GLP-1 and Inflammation and Arthritis Matter We now understand that GLP-1 medications are not just weight loss drugs. They are anti-inflammatory, immune-modulating, metabolic medications that can dramatically shift health outcomes for patients with arthritis and autoimmune diseases

Discuss the approach with your healthcare provider based on your tolerance history

Consistency Matters More Than Ingredients Alone No ingredient works overnight

Capuccio S, Scilletta S, La Rocca F, Miano N, Di Marco M, Bosco G, et al

Self-reported side effects associated with selective androgen receptor modulators: social media data analysis